Objective. The primary objective of this study was to assess the kinetics of ketoprofen in synovial fluid and intra-articular tissues in relation to plasma. The secondary objective was to study whether intra-articular tissues act as reservoirs.
There has been a growing interest in percutaneous that tissues may act as reservoir of ketoprofen, by evaluating tissue concentrations at various time points administration of anti-inflammatory drugs for the treatment of local conditions, one main feature being a after removal of the plaster, related to plasma. reduction in systemic exposure compared with oral administration. Ketoprofen [2-(3-benzoyl phenyl ) pro-
Materials and methods
pionic acid ] is a non-steroidal anti-inflammatory agent used in a variety of rheumatic and musculoskeletal
Patients to be included were of both sexes, aged conditions [1] . Ballerini et al. [2] showed high levels of 18-65 yr, suffering from knee disorders requiring arthroketoprofen in intra-articular adipose tissue and in capsuscopy. Exclusion criteria were a history of gastric or lar tissue after gel application. Low plasma and synovial duodenal ulcer, known hypersensitivity to non-steroidal fluid levels were found after ketoprofen gel applications anti-inflammatory drugs (NSAIDs), bronchial asthma (n = 12), compared with oral administration (n = 12), or allergic disease, pregnancy, open wounds or skin but a comparable tissue penetration, as assessed by pathology, serious concomitant renal, cardiac, hepatic similar concentrations in intra-articular tissues [3] . In or other disease. The minimum wash-out period prior another arm of the same study, we observed that topical to study treatment administration was 3 weeks for ketoprofen penetrated the skin into soft tissues and also ketoprofen, 1 week for any other form of NSAID or into the Achilles tendon [4] . steroids, and 24 h for aspirin. The study was approved The primary objective of this study was to assess by the local ethics committee at Huddinge University intra-articular absorption and distribution of ketoprofen Hospital Karolinska Institutet, Stockholm, Sweden, and after topical plaster application in relation to plasma monitored in accordance with good clinical practices level. The secondary objective was to attempt to verify and Rhô ne-Poulenc Rorer monitoring procedures. Before commencing the study, each patient gave their informed consent to participate and to adhere to the Submitted 10 March 1998; revised version accepted 10 February procedures described in the protocol.
1999.
Ketoprofen was administered either topically ( T; The mean duration of symptoms prior to surgery was plasma until the 24th hour of application [5] . The choice 17 months (range 10-26 months). The mean age was of oral dose was not based on an equipotency hypothesis 37.9 yr for the single-topical-application group (five of the topical and oral doses regarding pain relief, but females, 35 males), 35.8 yr for the multiple-application rather on the fact that 50 mg is a commonly used single group (seven females and 23 males) and 37 yr for the oral dose. Obviously, only one surgical sampling per oral intake group (nine females, 21 males). Weight, patient was possible. Surgery was performed at given stature and duration of symptoms prior to arthroscopy times (randomly allocated ) to explore various features did not differ between the groups. Three patients in the of ketoprofen kinetics: absorption and distribution after multiple-application group were either lost to follow-up single topical (1, 2, 6 and 14 h after application) and (n = 1) or withdrew their consent during the study oral administration (2, 6 and 14 h after intake), concen-(n = 2). trations at steady state and elimination after multiple Synovial fluid was taken from 80% (n = 32/40) of the topical administration (0, 6 and 14 h after removal of SA group, 70% (n = 20/28) of the MA patients and the last of five plasters). As substantiated below, 10 56.7% (n = 17/30) of the O group. Synovial tissue was subjects per sampling time were studied. Blinding of taken from 98% (n = 96/98), cartilage from 23% the administration was not deemed necessary due to (n = 23/98) and menisci from 52% (n = 51/98) of the the purely kinetic objective of the study. However, the patients, similar within each group. The specimens laboratory which performed the assays did not know varied inter-individually in weight, synovial tissue the treatment allocation.
(0.60-83.70 mg), cartilage (0-55.26 mg) and meniscus Blood samples were taken from an antecubital vein (0.43-64.77 mg). at baseline, and concomitant with the anterolateral skin Median concentrations at various sampling times, incision during arthroscopy. Biopsies were taken consecunumbers of samples with concentrations above the quantively: synovial fluid from a lateral position, from tification limit and number of samples available are synovial tissue under endoscopic visualization, and from presented in Table 1 . The main reason for concentrations cartilage and meniscus when appropriate ( loose bodies, below the quantification limit was the small weight of arthritis and partial meniscal tears). Samples were immethe sample. diately deep frozen.
After topical administration, ketoprofen penetrates The analyses of plasma, synovial fluid and tissue through the skin into the plasma, reaching a steady state samples were performed with a gas chromatography/ at 14 h which is maintained after repeated administration mass spectrometry (GC/MS assay) method after deriva-(18.1 ng/ml at 14 h after SA, 18.7 ng/ml at removal of tization (alkylation of the carboxyl group) of ketoprofen.
the last of five plasters in MA). Ketoprofen penetrates The linearity of this method was verified from 0.5 to through the skin into the synovial fluid, although the 100 ng/ml in plasma and from 0.5 to 100 ng/50 mg in steady state seems to be reached later than in plasma each tissue (synovial tissue-cartilage-meniscus) [6 ] . The (8.9 ng/ml at 14 h after SA, 12.8 ng/ml at removal of limit of quantification was validated at 0.5 ng/ml for the last of five plasters in MA); however, ketoprofen plasma and 0.5 ng/50 mg for tissues. Tissue concentrapenetrates into the synovial tissue apparently slower tions in nanograms per gram were calculated by using than in surrounding structures [below limit of quantiweights automatically transferred to an EXCEL profication (BLQ) at 14 h after SA, 56.7 ng/g at removal gram via a serial interface. The pharmacokinetic anaof the last of five plasters in MA]. Ketoprofen penetrates lyses of experimental data were performed at the into meniscus (349.3 ng/g at 14 h after SA) and in Department of Drug Metabolism and Pharmacokinetics, cartilage (569 ng/g at removal of the last of five plasters Rhô ne-Poulenc Rorer, Antony, France.
in MA). Owing to high interindividual variability mainly After oral application, concentrations in the plasma related to the high variability of the weight of collected and synovial fluid follow the known features for ketosamples, median, minimum and maximum individual profen, with a delayed curve in the synovial fluid; ketolevels and number of observations were used. The profen also penetrates into intra-articular tissues, the median maximum concentration (CMax) was the highest highest concentration being seen in synovial tissue. value observed after administration (single application)
Median CMax concentrations in fluids and intraor after removal of the plaster (multiple applications), articular tissues are presented in Table 2 . Topical and used for comparison between oral intake and topical administration/oral intake ratios were 0.2 for synovial administration. On the assumption of a mean concentratissue, 4.1 for meniscus and 6.8 for cartilage. tion of 0.25 ng/ml of ketoprofen in synovial fluid and tissues with a .. of 0.16, 10 subjects per sampling time Discussion would give a precision of 0.10 for the measure, i.e. a mean confidence interval length of <0.20. Plasma and
The two types of administration of ketoprofen evaluated in this study are fundamentally different. The kinetics synovial fluid levels were also expressed as the median T 1. Median concentrations of ketoprofen in plasma, synovial fluid and knee joint tissues (and mean synovial fluid/plasma ratios) after single (SA) this dose exceeds a small amount. The patch contains a large excess of active substance as compared to the absorption capacities of the skin, as demonstrated in a study based on urine excretion [3] , where only~6 mg state was reached, plasma and synovial fluid levels appeared comparable, as shown in the decline after of ketoprofen were absorbed through the skin during the 24 h during which the 30 mg plaster was worn, removal of the last plaster. The less impressive T/O ratio observed for synovial tissue is likely to be due to the Therefore, no measurement of doses actually absorbed was performed in this study, and no direct dose-adjusted fact that, contrary to meniscus and cartilage, this tissue is highly vascularized, and therefore receives ketoprofen comparison was made; however, it is worthwhile mentioning that, based on the above-mentioned study, 2 h both directly and through the general circulation, as known from previous studies. Similarly, due to the after application of the plaster, at most 1 mg would have been absorbed, to be compared to 50 mg after oral mechanism of formation of synovial fluid (mostly from the plasma), levels of drug in synovial fluid are not good administration.
This study shows that a direct penetration of ketoestimates of tissue penetration. The clearance rate of knee joint synovial fluid components has been shown to profen through the skin is most likely: 1 h after SA, some substance was measured in the synovial fluid in vary in different joint diseases [7] . With the limitation of few collected samples, our results indicate that intra-6/8 subjects, whereas no sample of plasma showed any measurable concentration; moreover, the median CMax articular tissues, such as cartilage and menisci, may act as reservoirs for ketoprofen. ratios T/O for meniscus and cartilage ( Table 2) , as well as the T/O ratio at 2 h after SA vs O (32.6/25.6 = 1.27), This study confirms that topical applications of ketoprofen allow the attainment of high intra-articular conclearly reinforce the hypothesis, mostly when considering the disparity of absorbed doses described above. After centrations, whereas plasma levels and systemic exposure are low. The high concentrations reached in cartilage topical application, steady state was achieved later in the synovial fluid than in plasma. However, once this raise the highly debated question of the deleterious effect
